Letter

Ramifications of screening for breast cancer: Definition of overdiagnosis is confusing in follow-up of Malmö trial

BMJ 2006; 332 doi: 10.1136/bmj.332.7543.727-b (Published 23 March 2006)
Cite this as: BMJ 2006;332:727.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Per-Henrik Zahl, senior statistician (per-henrik.zahl@fhi.no),
  2. Jan Mæhlen, professor
  1. Norwegian Institute of Public Health, PO Box 4404 Nydalen, N-0403, Oslo, Norway
  2. Department of Pathology, Ullevål University Hospital, N-0407 Oslo

    EDITOR—In their follow-up of the Malmö mammography trial, Zackrisson et al say that the reported levels of overdiagnosis vary from 5% to 50%.1 However, to use cumulative incidence rates at the end of follow-up to quantify the level of overdiagnosis is confusing because the resulting estimates are highly sensitive to both the length of follow-up and the length of …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular